Skip to main content
SpringerLink
Log in

Adjuvant therapy for melanoma: How should we respond to high-dose interferon?

  • Clinical Oncology
  • Published:
British Journal of Cancer Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Oncology Centre, Addenbrooke's NHS Trust, Cambridge, UK

    PG de Takats

Authors
  1. PG de Takats
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. MV Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Hawkins
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Takats, P., Williams, M. & Hawkins, R. Adjuvant therapy for melanoma: How should we respond to high-dose interferon?. Br J Cancer 77, 1287–1293 (1998). https://doi.org/10.1038/bjc.1998.215

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1998.215

  • Springer Nature Limited

Search

Navigation